A knowledge graph–driven literature-based discovery framework for drug repurposing in aplastic anaemia
Frontiers in Bioinformatics · 06.11.2026 · 6
DOI: 10.3389/fbinf.2026.1905251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 06.11.2026. Verfasst von Divya Sankar und 3 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Aplastic anaemia is a haematological disorder characterized by immune-mediated destruction of haematopoietic stem cells and bone marrow failure. Although immunosuppressive therapies are currently used, their lack of target specificity underscores the need for systematic approaches to identify precise therapeutic targets and explore drug repurposing opportunities.
Methods
A hybrid computational framework integrating literature-based discovery and database-driven validation was employed to construct a multi-layered biomedical knowledge graph. Semantic predications were extracted from SemMedDB and filtered using Unified Medical Language System semantic types to identify disease-, gene-, and drug-related entities. A tripartite disease–gene–drug network was constructed and subsequently extended into a heterogeneous knowledge graph by incorporating pathway-level interactions derived from enrichment analysis using clusterProfiler and KEGG. Drug–gene associations were further supported using curated resources such as DrugBank and DGIdb. Validation of gene–disease associations was performed using DisGeNET.
Results
The constructed knowledge graph revealed key genes, including CSF2, IL6, EPO, HLA-DRB1, and CD4, which are central to immune dysregulation and haematopoietic impairment. Pathway enrichment analysis identified critical pathways such as haematopoietic cell lineage, JAK–STAT signaling, cytokine–cytokine receptor interaction, and MAPK/ERK cascades, highlighting the interplay between immune signaling and bone marrow dysfunction. Integration of drug-related predications enabled the identification of both clinically used immunosuppressants and potential repurposing candidates, including mycophenolate mofetil, mizoribine, everolimus, and camostat mesylate. Mechanistic mapping of these drugs to key pathways suggests their potential to modulate aberrant immune responses and restore haematopoietic balance.
Conclusion
This study demonstrates the utility of a knowledge graph–based framework for integrating heterogeneous biomedical data to uncover multi-level interactions in aplastic anaemia. The approach enables systematic identification of biologically relevant genes, pathways, and drug candidates, supporting hypothesis-driven drug repurposing. While the findings are supported by literature and database validation, they remain exploratory and warrant further experimental and clinical investigation.
Zitieren
APA
Sankar, D., Bhasuran, B., Oviya, I. R., & Saranya, G. (2026). A knowledge graph–driven literature-based discovery framework for drug repurposing in aplastic anaemia. Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1905251
Vancouver
Sankar D, Bhasuran B, Oviya IR, Saranya G. A knowledge graph–driven literature-based discovery framework for drug repurposing in aplastic anaemia. Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1905251
BibTeX
@article{Sankar2026,
author = {Sankar, Divya and Bhasuran, Balu and Oviya, Iyyappan Ramalakshmi and Saranya, Gopu},
title = {A knowledge graph–driven literature-based discovery framework for drug repurposing in aplastic anaemia},
journal = {Frontiers in Bioinformatics},
year = {2026},
volume = {6},
doi = {10.3389/fbinf.2026.1905251}
}
EUVIMED